Connolly Gallagher attorneys successfully defended a director and board chairman of Transkaryotic Therapies (“TKT”) for alleged breach of fiduciary duty in connection with TKT’s acquisition by Shire Pharmaceuticals Group plc. The Court of Chancery’s opinion granting summary judgment can be found at 954 A.2d 346 (Del. Ch. 2008).
Please note that email communications to the firm through the website do not create an attorney-client relationship. Do not send any privileged or confidential information to the firm through the website.
Click “Accept” below to confirm that you have read and understand this notice.